Disclosures for "Peritumoral edema measurements provide additional information to RANO-BM based assessment of lung cancer brain metastases after Gamma Knife therapy ")
-
Miss Kaur has nothing to disclose.
-
Mr. Cassinelli Petersen has nothing to disclose.
-
Mr. Von Reppert has nothing to disclose.
-
Mr. Jekel has nothing to disclose.
-
Dr. Varghese has nothing to disclose.
-
Dr. Dixe de Oliveira Santo has nothing to disclose.
-
Dr. Omuro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $0-$499 for serving as a Consultant for Kiyatec. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pyramic. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curevac. Dr. Omuro has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Opinion in Neurology. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Agios. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Denovo Biopharma.
-
Dr. Chiang has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for monteris medical inc.
-
Dr. Aboian has a non-compensated relationship as a Principal Investigator with Visage Imaging that is relevant to AAN interests or activities.